GIUGLIANO, FEDERICA
 Distribuzione geografica
Continente #
EU - Europa 500
NA - Nord America 407
AS - Asia 389
SA - Sud America 36
OC - Oceania 25
AF - Africa 21
Totale 1.378
Nazione #
US - Stati Uniti d'America 373
IT - Italia 230
CN - Cina 166
GB - Regno Unito 60
IN - India 57
FR - Francia 47
JP - Giappone 45
DE - Germania 42
ES - Italia 24
HK - Hong Kong 24
AU - Australia 21
TR - Turchia 16
TW - Taiwan 15
BR - Brasile 14
CA - Canada 11
MY - Malesia 11
BE - Belgio 10
GR - Grecia 10
SA - Arabia Saudita 10
CL - Cile 9
MX - Messico 9
NL - Olanda 9
PL - Polonia 9
IR - Iran 8
KR - Corea 8
MA - Marocco 8
TT - Trinidad e Tobago 8
CH - Svizzera 7
CZ - Repubblica Ceca 6
HR - Croazia 6
IE - Irlanda 6
RO - Romania 6
CO - Colombia 5
EG - Egitto 5
FI - Finlandia 5
SE - Svezia 5
SG - Singapore 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
CU - Cuba 4
IL - Israele 4
NZ - Nuova Zelanda 4
EC - Ecuador 3
HU - Ungheria 3
ID - Indonesia 3
LB - Libano 3
PK - Pakistan 3
PT - Portogallo 3
UA - Ucraina 3
AR - Argentina 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
PH - Filippine 2
VN - Vietnam 2
ZA - Sudafrica 2
AM - Armenia 1
CI - Costa d'Avorio 1
CM - Camerun 1
GH - Ghana 1
JO - Giordania 1
LY - Libia 1
MK - Macedonia 1
PE - Perù 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
VE - Venezuela 1
Totale 1.378
Città #
Milan 67
Beijing 53
Ashburn 28
Rome 28
Columbus 25
Shanghai 16
Chicago 13
Naples 13
Boardman 11
New York 11
Central 10
Turin 10
Paris 9
Santiago 9
São Paulo 9
Athens 8
Boston 8
Kunming 8
London 8
Mumbai 8
Port of Spain 8
Seattle 8
Barcelona 7
Chennai 7
Gdansk 7
Guangzhou 7
Hong Kong 7
Istanbul 7
Los Angeles 7
Madrid 7
Tokyo 7
Adelaide 6
Ann Arbor 6
Berlin 6
Bologna 6
Brisbane 6
Buffalo 6
Fairfield 6
Hangzhou 6
Jeddah 6
Lucknow 6
San Jose 6
Santa Cruz 6
Brussels 5
Dublin 5
Fremont 5
Hefei 5
Mcallen 5
Rochester 5
San Francisco 5
Taipei 5
Atlanta 4
Dallas 4
Frankfurt am Main 4
Havana 4
Houston 4
Jinan 4
Kota Bharu 4
Mexico City 4
Ostrava 4
Rho 4
Santa Clara 4
Singapore 4
Taoyuan District 4
Tehran 4
Zagreb 4
Abiko 3
Abingdon 3
Amsterdam 3
Ankara 3
Auckland 3
Belmont 3
Bengaluru 3
Birmingham 3
Bogotá 3
Brooklyn 3
Bucharest 3
Casablanca 3
Cermenate 3
Delhi 3
Durham 3
Germantown 3
Hackensack 3
Hove 3
Hyderabad 3
Jaipur 3
Melbourne 3
New Brunswick 3
Oakland 3
Osaka 3
Padova 3
Princeton 3
Redmond 3
Rio de Janeiro 3
San Donà di Piave 3
Sassari 3
Steamboat Springs 3
Stockholm 3
Strasbourg 3
Suita 3
Totale 705
Nome #
Margetuximab for the treatment of HER2-positive metastatic breast cancer, file dfa8b9a6-578b-748b-e053-3a05fe0a3a96 852
Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer : a systematic review, file dfa8b9a7-0a7a-748b-e053-3a05fe0a3a96 258
Antibody–drug conjugates for the treatment of breast cancer, file dfa8b9a7-8e63-748b-e053-3a05fe0a3a96 78
Unlocking the Resistance to Anti-HER2 Treatments in Breast Cancer: The Issue of HER2 Spatial Distribution, file 7bdf0812-c6a5-45e4-b81c-9bd6063e8ad1 55
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents, file 3313c5a7-8117-463e-ac51-1492ce112453 43
Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management, file e322fc45-a51b-4eb9-a937-7d1012b995a2 25
Systemic Treatment of Ductal Carcinoma In Situ of the Breast, file dfa8b9a9-9c49-748b-e053-3a05fe0a3a96 22
Research and clinical landscape of bispecific antibodies for the treatment of solid malignancies, file dfa8b9a9-c373-748b-e053-3a05fe0a3a96 18
A set of easy and stringent criteria to identify immune-related adverse events (IrAE Scoring System, ISS) improves correlation with outcome in a phase 1-2 trial population, file 488bbd81-9e06-49ce-943b-eb05eb696b11 14
Auto-immune toxiity of Sars-Cov2 vaccine in patients with thymic epithelial tumours: a prospective analysis from the tyme net, file d304ca47-acb9-4fbc-8605-8f5268ce4dd8 4
Baseline tumor size as prognostic index in patients with cancer receiving experimental targeted agents, file 7274a766-ca39-47ea-b580-0b41c0acc128 2
Immune-related adverse events are correlated with significantly improved outcome in a phase I trial population exposed to combination immunotherapy, file 82391f77-cfe8-4eeb-ac5c-656d75dc4f52 2
HER2-Low Breast Cancer: a New Subtype?, file 2945c94b-1fa5-471e-aa48-0e3c2292cae8 1
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives, file 4745d05f-f547-438c-8011-ff54df4ec94f 1
Evolution of biological features of invasive lobular breast cancer: Comparison between primary tumour and metastases, file 4fa3ac33-2ece-4b72-92b2-df912202c535 1
Bystander effect of antibody-drug conjugates: fact or fiction?, file 9b8a5363-d112-47ba-ad54-83899ef33b4b 1
Characterization of low HER2 expressions in de-novo metastatic breast cancer, file bf38567a-0f9f-4a8e-8e20-0fa2d2e229ca 1
Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer : a systematic review, file dfa8b9a6-ee6c-748b-e053-3a05fe0a3a96 1
First line treatment of BRAF mutated advanced melanoma: Does one size fit all?, file dfa8b9a7-83d9-748b-e053-3a05fe0a3a96 1
Evolution of low HER2 expression between early and advanced-stage breast cancer, file dfa8b9a9-77e9-748b-e053-3a05fe0a3a96 1
Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions, file dfa8b9a9-84e4-748b-e053-3a05fe0a3a96 1
Clinical development and current role of margetuximab for the treatment of breast cancer, file dfa8b9a9-c449-748b-e053-3a05fe0a3a96 1
SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis, file e9b48976-a664-4203-812b-3fa408b00259 1
Totale 1.384
Categoria #
all - tutte 2.729
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.729


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 1 1 2
2021/2022246 6 4 1 2 3 1 2 32 47 50 59 39
2022/2023589 32 42 53 70 53 41 58 49 47 60 35 49
2023/2024545 40 46 49 41 58 62 54 53 37 46 59 0
Totale 1.384